These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24732868)

  • 1. Acid-based parameters on pH-impedance testing predict symptom improvement with medical management better than impedance parameters.
    Patel A; Sayuk GS; Gyawali CP
    Am J Gastroenterol; 2014 Jun; 109(6):836-44. PubMed ID: 24732868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease.
    Patel A; Sayuk GS; Gyawali CP
    Clin Gastroenterol Hepatol; 2015 May; 13(5):884-91. PubMed ID: 25158924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation.
    Patel A; Sayuk GS; Kushnir VM; Chan WW; Gyawali CP
    Neurogastroenterol Motil; 2016 Apr; 28(4):513-21. PubMed ID: 26686239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring.
    Patel A; Sayuk GS; Gyawali CP
    Neurogastroenterol Motil; 2016 Sep; 28(9):1382-90. PubMed ID: 27061427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distal mean nocturnal baseline impedance on pH-impedance monitoring predicts reflux burden and symptomatic outcome in gastro-oesophageal reflux disease.
    Patel A; Wang D; Sainani N; Sayuk GS; Gyawali CP
    Aliment Pharmacol Ther; 2016 Oct; 44(8):890-8. PubMed ID: 27554638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain.
    Kushnir VM; Sayuk GS; Gyawali CP
    Am J Gastroenterol; 2010 May; 105(5):1032-8. PubMed ID: 19920808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychosocial Distress and Quality of Life Impairment Are Associated With Symptom Severity in PPI Non-Responders With Normal Impedance-pH Profiles.
    Yadlapati R; Tye M; Keefer L; Kahrilas PJ; Pandolfino JE
    Am J Gastroenterol; 2018 Jan; 113(1):31-38. PubMed ID: 28895583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of pH Impedance Monitoring While on Twice-Daily Proton Pump Inhibitor Therapy to Identify Need for Escalation of Reflux Management.
    Gyawali CP; Tutuian R; Zerbib F; Rogers BD; Frazzoni M; Roman S; Savarino E; de Bortoli N; Vela MF; Sifrim D
    Gastroenterology; 2021 Nov; 161(5):1412-1422. PubMed ID: 34270955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multichannel intraluminal impedance in the evaluation of patients with persistent globus on proton pump inhibitor therapy.
    Anandasabapathy S; Jaffin BW
    Ann Otol Rhinol Laryngol; 2006 Aug; 115(8):563-70. PubMed ID: 16944654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn.
    Frazzoni M; Conigliaro R; Mirante VG; Melotti G
    Neurogastroenterol Motil; 2012 Feb; 24(2):141-6, e87. PubMed ID: 21988704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication.
    Frazzoni M; Piccoli M; Conigliaro R; Manta R; Frazzoni L; Melotti G
    Surg Endosc; 2013 Aug; 27(8):2940-6. PubMed ID: 23436097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial intelligence automates and augments baseline impedance measurements from pH-impedance studies in gastroesophageal reflux disease.
    Rogers B; Samanta S; Ghobadi K; Patel A; Savarino E; Roman S; Sifrim D; Gyawali CP
    J Gastroenterol; 2021 Jan; 56(1):34-41. PubMed ID: 33151406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy.
    Blonski W; Vela MF; Castell DO
    J Clin Gastroenterol; 2009 Oct; 43(9):816-20. PubMed ID: 19398927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors.
    Becker V; Grotz S; Schlag C; Nennstiel S; Beitz A; Haller B; Schmid RM; Meining A; Bajbouj M
    World J Gastroenterol; 2014 Apr; 20(14):4017-24. PubMed ID: 24744591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of antisecretory therapy and study duration on ambulatory esophageal pH monitoring.
    Kushnir VM; Sayuk GS; Gyawali CP
    Dig Dis Sci; 2011 May; 56(5):1412-9. PubMed ID: 21046245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoscopic measurement of gastric pH associates with persistent acid reflux in patients treated with proton-pump inhibitors for gastroesophageal reflux disease.
    Januszewicz W; Hartley J; Waldock W; Roberts G; Alias B; Hobson A; Wernisch L; di Pietro M
    United European Gastroenterol J; 2019 Dec; 7(10):1389-1398. PubMed ID: 31807307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of concordance of symptom reflux association tests in ambulatory pH monitoring.
    Kushnir VM; Sathyamurthy A; Drapekin J; Gaddam S; Sayuk GS; Gyawali CP
    Aliment Pharmacol Ther; 2012 May; 35(9):1080-7. PubMed ID: 22428660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mean Nocturnal Baseline Impedance Correlates With Symptom Outcome When Acid Exposure Time Is Inconclusive on Esophageal Reflux Monitoring.
    Rengarajan A; Savarino E; Della Coletta M; Ghisa M; Patel A; Gyawali CP
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):589-595. PubMed ID: 31163276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.